Bumbacher M, Roth A
Klin Monbl Augenheilkd. 1985 Jun;186(6):488-90. doi: 10.1055/s-2008-1050966.
Corticotherapy has been proposed several times for the treatment of venous thrombosis of the retina (e.g., Hayreh 1975). Since 1975 the present authors have used it regularly, combined with heparinotherapy, for all types of retinal vascular occlusion, in the form of retrobulbar injections of corticoids. The aim is to reduce edema of the vascular wall at the occlusion and re-establish or improve the flow, and thereby protect the sensory cells during the critical repair period. In edematous or mixed types of venous thrombosis, the effectiveness of the treatment is demonstrated by a rapid improvement in acuity. As recommended by Hayreh, corticotherapy is certainly indicated for edematous and mixed thromboses with loss of central field acuity. In other types of vascular occlusions (ischemic venous thrombosis, arterial occlusion, and vascular papillitis) the benefit can only be guessed at. Corticotherapy is not a replacement for anticoagulation, laser coagulation, or general treatment.
皮质激素疗法已多次被提议用于治疗视网膜静脉血栓形成(例如,Hayreh,1975年)。自1975年以来,作者们一直定期将其与肝素疗法联合使用,以球后注射皮质激素的形式用于治疗所有类型的视网膜血管阻塞。目的是减轻阻塞部位血管壁的水肿,恢复或改善血流,从而在关键的修复期保护感觉细胞。在水肿型或混合型静脉血栓形成中,视力的迅速改善证明了该治疗方法的有效性。正如Hayreh所建议的,对于伴有中心视野视力丧失的水肿型和混合型血栓形成,皮质激素疗法肯定是适用的。在其他类型的血管阻塞(缺血性静脉血栓形成、动脉阻塞和血管性视乳头炎)中,其益处只能推测。皮质激素疗法不能替代抗凝治疗、激光凝固治疗或一般治疗。